LINC02683

Across TCGA pan-cancer cohorts, LINC02683 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02683’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02683 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02683 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LUAD, KIRC, and KIRP are the cancer types where LINC02683 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02683 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	II,III,IV	+0.428	<.001	8	view →
KIRC	All	All	+0.330	<.001	8	view →
KIRP	All	All	+0.403	<.001	7	view →
KICH	Male	All	−0.278	<.001	6	view →
THCA	Male	All	+0.118	.001	5	view →
PAAD	Male	All	+0.180	.026	2	view →
LUSC	All	All	+0.053	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02683–LUAD

Open the LUAD breakdown →